Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis
Camilo J. Rojas, Mithun R. Raje, Takashi Tsukamoto et al. · European Journal of Pharmacology · 2013
Cited by 162 works. doi:10.1016/j.ejphar.2013.08.049
Authors
References
- An unidentified depressor substance in certain tissue extracts
- Platinum Compounds: a New Class of Potent Antitumour Agents
- Isolation of a Sialogogic Peptide from Bovine Hypothalamic Tissue and Its Characterization as Substance P
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs
- A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonism
- Comparison of the 5-Hydroxytryptamine 3 (Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
- Cell Surface Receptors: A Short Course on Theory and Methods
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting